
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $92.5M | $108.6M | $91.9M | $39.8M | $46.6M | |
Revenue Growth (YoY) | -24.33% | 17.36% | -15.31% | -56.66% | 17.06% | |
Cost of Revenues | $74.6M | $84.7M | $106.7M | $33.4M | $103M | |
Gross Profit | $17.9M | $23.9M | -$14.8M | $6.4M | -$56.4M | |
Gross Profit Margin | 19.37% | 22.01% | -16.06% | 16.18% | -120.88% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $11M | $9.5M | $10.1M | $10.6M | $11.1M | |
Other Inc / (Exp) | $30.3M | $35.9M | $41.1M | $11.5M | $81.6M | |
Operating Expenses | $11M | $9.5M | $10.1M | $10.6M | $11.1M | |
Operating Income | $6.9M | $14.4M | -$24.8M | -$4.2M | -$67.5M | |
Net Interest Expenses | $5.9M | $4M | $3.3M | $4.9M | $3.2M | |
EBT. Incl. Unusual Items | $31.4M | $46.4M | $13M | $2.5M | $11M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $7.7M | $11.6M | $1.1M | $801K | $4.6M | |
Net Income to Company | $23.7M | $34.8M | $11.9M | $1.7M | $6.4M | |
Minority Interest in Earnings | -$52K | $39K | $573K | $177K | $618K | |
Net Income to Common Excl Extra Items | $23.7M | $34.9M | $12.5M | $1.8M | $7M | |
Basic EPS (Cont. Ops) | $3.16 | $4.64 | $1.65 | $0.24 | $0.91 | |
Diluted EPS (Cont. Ops) | $3.16 | $4.64 | $1.65 | $0.24 | $0.91 | |
Weighted Average Basic Share | $7.5M | $7.6M | $7.6M | $7.6M | $7.6M | |
Weighted Average Diluted Share | $7.5M | $7.6M | $7.6M | $7.6M | $7.6M | |
EBITDA | $51.6M | $65.5M | $31.5M | $22.9M | $29.5M | |
EBIT | $37.4M | $50.4M | $16.3M | $7.4M | $14.5M | |
Revenue (Reported) | $92.5M | $108.6M | $91.9M | $39.8M | $46.6M | |
Operating Income (Reported) | $6.9M | $14.4M | -$24.8M | -$4.2M | -$67.5M | |
Operating Income (Adjusted) | $37.4M | $50.4M | $16.3M | $7.4M | $14.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $55.9M | $49.6M | $21.3M | $18.1M | $18M | |
Revenue Growth (YoY) | 10.75% | -11.27% | -57.1% | -14.94% | -0.73% | |
Cost of Revenues | $45.7M | $45.6M | $27.6M | $36.3M | $167.7M | |
Gross Profit | $10.2M | $4M | -$6.3M | -$18.2M | -$149.7M | |
Gross Profit Margin | 18.28% | 8.06% | -29.72% | -100.25% | -832.58% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.7M | $2.5M | $2.7M | $2.3M | $3.4M | |
Other Inc / (Exp) | -$15K | $26.6M | $1.6M | $4K | $15.9M | |
Operating Expenses | $2.7M | $2.5M | $2.7M | $2.3M | $3.4M | |
Operating Income | $7.6M | $1.5M | -$9M | -$20.5M | -$153.1M | |
Net Interest Expenses | $1.1M | $870K | $1.3M | $508K | $1.1M | |
EBT. Incl. Unusual Items | $6.5M | $27.2M | -$8.7M | -$21M | -$138.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.6M | $6.6M | -$534K | -$5M | -$26.9M | |
Net Income to Company | $4.9M | $20.6M | -$8.1M | -$16M | -$111.4M | |
Minority Interest in Earnings | -$23K | $85K | $344K | $209K | $48K | |
Net Income to Common Excl Extra Items | $4.9M | $20.7M | -$7.8M | -$15.8M | -$111.4M | |
Basic EPS (Cont. Ops) | $0.65 | $2.74 | -$1.02 | -$2.07 | -$14.58 | |
Diluted EPS (Cont. Ops) | $0.65 | $2.74 | -$1.02 | -$2.07 | -$14.58 | |
Weighted Average Basic Share | $7.5M | $7.6M | $7.6M | $7.6M | $7.6M | |
Weighted Average Diluted Share | $7.5M | $7.6M | $7.6M | $7.6M | $7.6M | |
EBITDA | $11.4M | $31.9M | -$3.5M | -$16.5M | -$14.7M | |
EBIT | $7.6M | $28.1M | -$7.4M | -$20.3M | -$137.2M | |
Revenue (Reported) | $55.9M | $49.6M | $21.3M | $18.1M | $18M | |
Operating Income (Reported) | $7.6M | $1.5M | -$9M | -$20.5M | -$153.1M | |
Operating Income (Adjusted) | $7.6M | $28.1M | -$7.4M | -$20.3M | -$137.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $100.7M | $103.9M | $58.9M | $40.1M | $49.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $79.4M | $89.8M | $89.6M | $55.9M | $231.3M | |
Gross Profit | $21.3M | $14.1M | -$30.7M | -$15.8M | -$181.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $10.5M | $9.4M | $10.1M | $11.1M | $11.5M | |
Other Inc / (Exp) | $30.9M | $67.6M | $10.8M | $83.7M | $20.6M | |
Operating Expenses | $10.5M | $9.4M | $10.1M | $11.1M | $11.5M | |
Operating Income | $10.8M | $4.7M | -$40.8M | -$26.9M | -$193.4M | |
Net Interest Expenses | $5.2M | $3.5M | $4M | $4.4M | $3.1M | |
EBT. Incl. Unusual Items | $36.6M | $68.8M | -$34M | $52.4M | -$175.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $8.6M | $12M | -$3.8M | $13M | -$35.1M | |
Net Income to Company | $27.9M | $56.8M | -$30.1M | $39.4M | -$140.8M | |
Minority Interest in Earnings | $68K | $157K | $817K | $515K | $32K | |
Net Income to Common Excl Extra Items | $28M | $57M | -$29.3M | $39.9M | -$140.7M | |
Basic EPS (Cont. Ops) | $3.74 | $7.56 | -$3.86 | $5.25 | -$18.43 | |
Diluted EPS (Cont. Ops) | $3.74 | $7.56 | -$3.86 | $5.25 | -$18.43 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $56.5M | $87.5M | -$14.6M | $72.4M | -$38.8M | |
EBIT | $41.8M | $72.3M | -$30M | $57.2M | -$172.5M | |
Revenue (Reported) | $100.7M | $103.9M | $58.9M | $40.1M | $49.4M | |
Operating Income (Reported) | $10.8M | $4.7M | -$40.8M | -$26.9M | -$193.4M | |
Operating Income (Adjusted) | $41.8M | $72.3M | -$30M | $57.2M | -$172.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $69.7M | $65M | $31.9M | $32.1M | $34.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $54.1M | $59.2M | $42M | $64.5M | $192.8M | |
Gross Profit | $15.6M | $5.8M | -$10.1M | -$32.4M | -$157.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.2M | $5.1M | $5.2M | $5.6M | $6M | |
Other Inc / (Exp) | $3.4M | $35.1M | $4.8M | $77M | $16.1M | |
Operating Expenses | $5.2M | $5.1M | $5.2M | $5.6M | $6M | |
Operating Income | $10.4M | $688K | -$15.3M | -$38M | -$163.9M | |
Net Interest Expenses | $2.3M | $1.8M | $2.4M | $2M | $2M | |
EBT. Incl. Unusual Items | $11.5M | $34M | -$12.9M | $37M | -$149.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.8M | $3.3M | -$1.6M | $10.6M | -$29.1M | |
Net Income to Company | $8.7M | $30.7M | -$11.3M | $26.4M | -$120.7M | |
Minority Interest in Earnings | $18K | $136K | $380K | $718K | $132K | |
Net Income to Common Excl Extra Items | $8.7M | $30.8M | -$10.9M | $27.1M | -$120.6M | |
Basic EPS (Cont. Ops) | $1.16 | $4.08 | -$1.43 | $3.57 | -$15.78 | |
Diluted EPS (Cont. Ops) | $1.16 | $4.08 | -$1.43 | $3.57 | -$15.78 | |
Weighted Average Basic Share | $15M | $15.1M | $15.2M | $15.2M | $15.3M | |
Weighted Average Diluted Share | $15M | $15.1M | $15.2M | $15.2M | $15.3M | |
EBITDA | $21.4M | $43.4M | -$2.7M | $46.9M | -$21.4M | |
EBIT | $13.8M | $35.7M | -$10.5M | $39.3M | -$147.7M | |
Revenue (Reported) | $69.7M | $65M | $31.9M | $32.1M | $34.9M | |
Operating Income (Reported) | $10.4M | $688K | -$15.3M | -$38M | -$163.9M | |
Operating Income (Adjusted) | $13.8M | $35.7M | -$10.5M | $39.3M | -$147.7M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $3.2M | $886K | $865K | $1.1M | $3.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $4.3M | $6.1M | $324K | $712K | $771K | |
Inventory | $40.9M | $43.4M | $27.7M | $52.5M | $30.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.4M | $1.2M | $1.4M | $1.7M | $1.6M | |
Total Current Assets | $51.9M | $54.9M | $31.6M | $58.8M | $40.6M | |
Property Plant And Equipment | $350.1M | $373.2M | $372.5M | $361.8M | $352.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $19.7M | $2.8M | $2.9M | $5.5M | $3.1M | |
Total Assets | $423.9M | $433.2M | $409.3M | $428.4M | $398.7M | |
Accounts Payable | $3.5M | $7.3M | $3.4M | $6.3M | $3.4M | |
Accrued Expenses | $4.4M | $4.1M | $3.2M | $2.8M | $3.1M | |
Current Portion Of Long-Term Debt | -- | $4.3M | $3M | $2.6M | $1.4M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1.4M | $875K | $1.1M | $825K | $513K | |
Total Current Liabilities | $21.2M | $22.3M | $16.5M | $15.1M | $10.7M | |
Long-Term Debt | $140.9M | $121M | $107.8M | $126.1M | $90.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $202.2M | $183.1M | $160.4M | $178M | $142.4M | |
Common Stock | $8.4M | $8.4M | $8.4M | $8.4M | $8.4M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $216.3M | $244.7M | $243.7M | $245M | $251.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $5.4M | $5.4M | $5.1M | $5.4M | $5.1M | |
Total Equity | $221.8M | $250.1M | $248.9M | $250.4M | $256.3M | |
Total Liabilities and Equity | $423.9M | $433.2M | $409.3M | $428.4M | $398.7M | |
Cash and Short Terms | $3.2M | $886K | $865K | $1.1M | $3.2M | |
Total Debt | $150M | $125.3M | $110.9M | $128.7M | $92.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $10.4M | $23.5M | $148K | $6M | $14.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $11M | $12.5M | $9M | $9.4M | $10M | |
Inventory | $30M | $33.2M | $23.4M | $29.7M | $7.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.4M | $1.2M | $1.4M | $1.6M | $1.2M | |
Total Current Assets | $54.9M | $70.6M | $37M | $51.6M | $44M | |
Property Plant And Equipment | $369M | $373.9M | $369.1M | $360.2M | $194M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $2.6M | $6.2M | $3.2M | $2.7M | $3M | |
Total Assets | $428.8M | $452.9M | $411.6M | $416.8M | $243.2M | |
Accounts Payable | $11.8M | $7.4M | $8M | $6.9M | $2.2M | |
Accrued Expenses | $3.1M | $3.5M | $2.7M | $2.4M | $2.3M | |
Current Portion Of Long-Term Debt | $8.4M | $4.3M | $1.6M | $1.4M | $1.4M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $761K | $811K | $880K | $515K | $674K | |
Total Current Liabilities | $27M | $24.5M | $14.3M | $20.2M | $7.9M | |
Long-Term Debt | $133.4M | $119M | $124M | $83M | $88.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $200.4M | $181.4M | $174.2M | $140.4M | $108M | |
Common Stock | $8.4M | $8.4M | $8.4M | $8.4M | $8.4M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $5.4M | $5.3M | $4.7M | $4.7M | $5M | |
Total Equity | $228.4M | $271.6M | $237.3M | $276.4M | $135.2M | |
Total Liabilities and Equity | $428.8M | $452.9M | $411.6M | $416.8M | $243.2M | |
Cash and Short Terms | $10.4M | $23.5M | $148K | $6M | $14.7M | |
Total Debt | $141.8M | $123.2M | $125.6M | $84.4M | $89.6M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $23.7M | $34.8M | $11.9M | $1.7M | $6.4M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | $1.3M | $1.2M | $1.2M | $935K | $719K | |
Change in Accounts Receivable | -$4.4M | -$4.2M | $7.9M | -$472K | -$817K | |
Change in Inventories | -$712K | -$2.5M | -$5.9M | -$26.4M | -$26.3M | |
Cash From Operations | $1M | $16.5M | $6.5M | -$6.3M | -$30.5M | |
Capital Expenditures | $22.2M | $22.3M | $20.7M | $16.7M | $17.9M | |
Cash Acquisitions | -- | -$18.5M | -$136K | -$77K | -- | |
Cash From Investing | $9.5M | -$3.3M | $22.5M | -$4.1M | $68.2M | |
Dividends Paid (Ex Special Dividend) | -$2.5M | -$7.1M | -$15.1M | -$4.9M | -$1.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $117.5M | $47.8M | $57.2M | $79.3M | $36.9M | |
Long-Term Debt Repaid | -$129.8M | -$72.7M | -$71.8M | -$61.6M | -$73.8M | |
Repurchase of Common Stock | -$238K | -- | -- | -- | -- | |
Other Financing Activities | $271K | -- | $294K | $441K | $368K | |
Cash From Financing | -$14.7M | -$32M | -$29M | $13.2M | -$38M | |
Beginning Cash (CF) | $23.8M | $19.7M | $886K | $865K | $3.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$4.2M | -$18.8M | -$21K | $2.8M | -$294K | |
Ending Cash (CF) | $19.7M | $886K | $865K | $3.7M | $3.4M | |
Levered Free Cash Flow | -$21.1M | -$5.8M | -$14.2M | -$22.9M | -$48.4M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $27.1M | $2.7M | $12.1M | -$1.9M | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | $322K | $304K | $198K | $175K | -- | |
Change in Accounts Receivable | $4.5M | $7.9M | $6.4M | $4.9M | -- | |
Change in Inventories | -$1.5M | -$5.8M | -$15.4M | -$6.7M | -- | |
Cash From Operations | $8M | $2M | $6.5M | $1M | -- | |
Capital Expenditures | $5.9M | $4.6M | $4.5M | $4.4M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $25.8M | $1.5M | -$1.6M | $2.9M | -- | |
Dividends Paid (Ex Special Dividend) | -$1.4M | -$3.8M | -$380K | -$380K | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $5.3M | -- | $23.7M | -- | -- | |
Long-Term Debt Repaid | -$16.8M | -$16.7M | -$27.2M | -$352K | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $441K | -- | -- | |
Cash From Financing | -$12.8M | -$20.2M | -$3.4M | -$732K | -- | |
Beginning Cash (CF) | $10.4M | $26.2M | $148K | $6M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $21M | -$16.6M | $1.4M | $3.1M | -- | |
Ending Cash (CF) | $31.4M | $9.5M | $1.6M | $9.1M | -- | |
Levered Free Cash Flow | $2.1M | -$2.6M | $2M | -$3.4M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $27.9M | $56.8M | -$30.1M | $39.4M | -$140.8M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | $1.1M | $1.2M | $1.1M | $771K | $714K | |
Change in Accounts Receivable | -$6.6M | -$1.5M | $702K | $2.5M | -$1.7M | |
Change in Inventories | -$1.5M | -$3.1M | -$13.4M | -$35M | -$7.4M | |
Cash From Operations | $15M | -$324K | -$9.4M | -$18.9M | -$11.3M | |
Capital Expenditures | $40.7M | $4.4M | $18.5M | $20.1M | $9.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$8.1M | $47.3M | -$7.6M | $67.2M | $16.9M | |
Dividends Paid (Ex Special Dividend) | -$3.4M | -$12.6M | -$11.7M | -$1.5M | -$1.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $74.3M | $52M | $51.9M | $57.4M | $36.9M | |
Long-Term Debt Repaid | -$151.8M | -$70.7M | -$49.7M | -$98.8M | -$31.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$80.5M | -$31.2M | -$9M | -$42.5M | $3.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$73.7M | $15.8M | -$26M | $5.8M | $9.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$25.7M | -$4.7M | -$27.9M | -$39M | -$20.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $35.8M | $33.4M | $755K | $24.5M | -$120.7M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | $952K | $934K | $731K | $544K | $364K | |
Change in Accounts Receivable | -$1.4M | $4.7M | -$4M | -$2.6M | -$8.3M | |
Change in Inventories | $9.3M | $4.4M | -$12.8M | -$12.6M | $12.9M | |
Cash From Operations | $33.6M | $10.8M | -$618K | -$18.7M | -$571K | |
Capital Expenditures | $34.4M | $15.2M | $13M | $16.3M | $3.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $1.3M | $27.5M | -$5.7M | $70.1M | $16M | |
Dividends Paid (Ex Special Dividend) | -$3.4M | -$11.3M | -$4.6M | -$1.1M | -$764K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $47.6M | $46.5M | $64.9M | $19.3M | $19.3M | |
Long-Term Debt Repaid | -$67.4M | -$65.3M | -$53.8M | -$64.1M | -$21.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $441K | -- | -- | |
Cash From Financing | -$23.1M | -$29.7M | $7.1M | -$46M | -$3.4M | |
Beginning Cash (CF) | $32.7M | $27.1M | $1.3M | $30.9M | $8.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.7M | $8.6M | $727K | $5.4M | $12M | |
Ending Cash (CF) | $44.4M | $35.8M | $2M | $36.3M | $20.6M | |
Levered Free Cash Flow | -$835K | -$4.5M | -$13.6M | -$35M | -$4.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.